LDC-9-A

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLDC-9-A
Drug Alias Namecyclin-dependent kinase-9 inhibitors (Lead Discovery)CDK-9 inhibitors (Lead Discovery)LDC-9-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLead Discovery Center GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLead Discovery Center GmbH
Active IndicationsN/A
Inactive IndicationsInflammationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A